Paolo Cassano MD, PhD, Massachusetts General Hospital, Assistant Professor of Psychiatry, Harvard Medical School discusses a new way of categorizing continuous-wave, near-infrared, transcranial treatments that have otherwise been lumped into one modality (tPBM).
Transcranial Photobiomodulation in the Treatment of Psychiatric Disorders: Ca...Paolo Cassano, MD, PhD
From Machine to Mind: Can We Close the Loop? At the 2019 Mind-Body Interface International Symposium (Taiwan): Dr Paolo Cassano suggests that machines shedding near-infrared light onto the head could communicate with the mind.
Transcranial Photobiomodulation for Autism Spectrum Disorder (ASD) Paolo Cassano, MD, PhD
Several studies are on the way to assess the impact of transcranial photobiomodulation (tPBM) with infrared light on Autism in both adults and children. Read the preliminary evidence from both Massachusetts General Hospital and other groups.
At the 2021 Society of Biological Psychiatry (SOBP - May 1st), Dr. Cassano presented on “Transcranial Near-Infrared Light for Brain Injury and Neurodegeneration”. He argued that the experience with photobiomodulation (PBM) for the treatment of major depressive disorder can inform the use of PBM in Alzheimer’s disease: current NIH Multicenter Trials are mentioned.
Transcranial Photobiomodulation Dosimetry: Integrating Human Data and Penetra...Paolo Cassano, MD, PhD
Is there enough light in your brain? Dr. Paolo Cassano presents at the 2020 Society of Biological Psychiatry meeting. Using the Monte Carlo eXtreme Simulation Model (MCX), predictions were made over the penetration of light into the brain and its potential for clinical and neurophysiological impacts.
Carrie Bearden: Studying Psychosis in 22q11 Deletion Syndromewef
Presentation made at the live webinar hosted by Schizophrenia Research Forum on the 28th of July, 2016, titled Studying Psychosis in 22q11 Deletion Syndrome. Additional recording and materials available at the SRF website: http://www.schizophreniaforum.org/for/live/detail.asp?liveID=100
Transcranial Photobiomodulation in the Treatment of Psychiatric Disorders: Ca...Paolo Cassano, MD, PhD
From Machine to Mind: Can We Close the Loop? At the 2019 Mind-Body Interface International Symposium (Taiwan): Dr Paolo Cassano suggests that machines shedding near-infrared light onto the head could communicate with the mind.
Transcranial Photobiomodulation for Autism Spectrum Disorder (ASD) Paolo Cassano, MD, PhD
Several studies are on the way to assess the impact of transcranial photobiomodulation (tPBM) with infrared light on Autism in both adults and children. Read the preliminary evidence from both Massachusetts General Hospital and other groups.
At the 2021 Society of Biological Psychiatry (SOBP - May 1st), Dr. Cassano presented on “Transcranial Near-Infrared Light for Brain Injury and Neurodegeneration”. He argued that the experience with photobiomodulation (PBM) for the treatment of major depressive disorder can inform the use of PBM in Alzheimer’s disease: current NIH Multicenter Trials are mentioned.
Transcranial Photobiomodulation Dosimetry: Integrating Human Data and Penetra...Paolo Cassano, MD, PhD
Is there enough light in your brain? Dr. Paolo Cassano presents at the 2020 Society of Biological Psychiatry meeting. Using the Monte Carlo eXtreme Simulation Model (MCX), predictions were made over the penetration of light into the brain and its potential for clinical and neurophysiological impacts.
Carrie Bearden: Studying Psychosis in 22q11 Deletion Syndromewef
Presentation made at the live webinar hosted by Schizophrenia Research Forum on the 28th of July, 2016, titled Studying Psychosis in 22q11 Deletion Syndrome. Additional recording and materials available at the SRF website: http://www.schizophreniaforum.org/for/live/detail.asp?liveID=100
Erik Boot - Studying Psychosis in 22q11 Deletion Syndromewef
Presentation made July 28, 2016 at the live webinar hosted by the Schizophrenia Research Forum and titled Studying Psychosis in 22q11 Deletion Syndrome. More details and video recording at http://www.schizophreniaforum.org/for/live/detail.asp?liveID=100
Migraine (Headaches) Disease Data Classification Using Data Mining ClassifiersQUESTJOURNAL
ABSTRACT: The Paper has analyzed migraine headache using four classification technique K-NN, SVM, Random Forest, & Naïve Bays. Overall in 30 days a month getting migraine pain which intensity of pain between 1-10 which may be occurred in some hours, including pain of location, environmental factors and their associated symptoms. The data is being collected from headache diary. In this database, with 114 different data’s having 6 different categories have been considered to conduct the experimentation with proposed migraine headache classification technique. On the whole on hundred and fourteen queries have been fired. The average success rate of classification determination for each of the categorical attributes has been classified using four classifiers. The results explicitly reveal performance improvement with proposed migraine headache classification compare to intensity of pain, environment factors and their associated symptoms which is the best results Naïve Bays Classification technique among four
What’s next: The future of non-invasive neurotechnologySharpBrains
(Session held at the 2014 SharpBrains Virtual Summit; October 28-30th, 2014)
3-4pm. What’s next: The future of non-invasive neurotechnology
- Dr. Bruce Cuthbert, Director of Adult Translational Research and Treatment Development at the NIMH
- Charles Fisher, President of Fisher Wallace Laboratories
- Chair: James Cavuoto, Editor and Publisher at Neurotech Reports
Learn more here:
http://sharpbrains.com/summit-2014/agenda/
In Feb 2022, Dr. Cassano presented this NYU-MGH study at LifeStance Health. The presentation covers in-vitro and pre-clinical data in support of the use of transcranial PBM for Alzheimer’s disease (AD). The most recent clinical data on PBM for AD were also reviewed. The NYU-MGH study was described: a large randomized, double-blind clinical trial (n=125) sponsored by NIH/NIA and by the Alzheimer’s Association.
Effect and maintenance of "EEG-biofeedback rTMS" on mood and working memory ...Amin Asadollahpour Kargar
This is a proposal presented in the 1st IBRO/APRC Iranian Associate School of Cognitive Neuroscience “Functional Human Brain Mapping”, Tehran, Iran, May 22-28, 2015
aimed:
1. To evaluate the effect of EEG-biofeedback rTMS on Mood in major depressed patients compare to EEG biofeedback and rTMS
2. To evaluate the maintenance of EEG-biofeedback rTMS on working memory in major depressed patients compare to EEG biofeedback and rTMS
Treating Treatment Refractory Depression With TMS, Transcranial Magnetic Stimulation. TMS is for patients suffering from depression who have not achieved satisfactory improvement from prior antidepressant treatment. These slides show research and anecdotes taken from actual results of patients who've tried TMS.
Erik Boot - Studying Psychosis in 22q11 Deletion Syndromewef
Presentation made July 28, 2016 at the live webinar hosted by the Schizophrenia Research Forum and titled Studying Psychosis in 22q11 Deletion Syndrome. More details and video recording at http://www.schizophreniaforum.org/for/live/detail.asp?liveID=100
Migraine (Headaches) Disease Data Classification Using Data Mining ClassifiersQUESTJOURNAL
ABSTRACT: The Paper has analyzed migraine headache using four classification technique K-NN, SVM, Random Forest, & Naïve Bays. Overall in 30 days a month getting migraine pain which intensity of pain between 1-10 which may be occurred in some hours, including pain of location, environmental factors and their associated symptoms. The data is being collected from headache diary. In this database, with 114 different data’s having 6 different categories have been considered to conduct the experimentation with proposed migraine headache classification technique. On the whole on hundred and fourteen queries have been fired. The average success rate of classification determination for each of the categorical attributes has been classified using four classifiers. The results explicitly reveal performance improvement with proposed migraine headache classification compare to intensity of pain, environment factors and their associated symptoms which is the best results Naïve Bays Classification technique among four
What’s next: The future of non-invasive neurotechnologySharpBrains
(Session held at the 2014 SharpBrains Virtual Summit; October 28-30th, 2014)
3-4pm. What’s next: The future of non-invasive neurotechnology
- Dr. Bruce Cuthbert, Director of Adult Translational Research and Treatment Development at the NIMH
- Charles Fisher, President of Fisher Wallace Laboratories
- Chair: James Cavuoto, Editor and Publisher at Neurotech Reports
Learn more here:
http://sharpbrains.com/summit-2014/agenda/
In Feb 2022, Dr. Cassano presented this NYU-MGH study at LifeStance Health. The presentation covers in-vitro and pre-clinical data in support of the use of transcranial PBM for Alzheimer’s disease (AD). The most recent clinical data on PBM for AD were also reviewed. The NYU-MGH study was described: a large randomized, double-blind clinical trial (n=125) sponsored by NIH/NIA and by the Alzheimer’s Association.
Effect and maintenance of "EEG-biofeedback rTMS" on mood and working memory ...Amin Asadollahpour Kargar
This is a proposal presented in the 1st IBRO/APRC Iranian Associate School of Cognitive Neuroscience “Functional Human Brain Mapping”, Tehran, Iran, May 22-28, 2015
aimed:
1. To evaluate the effect of EEG-biofeedback rTMS on Mood in major depressed patients compare to EEG biofeedback and rTMS
2. To evaluate the maintenance of EEG-biofeedback rTMS on working memory in major depressed patients compare to EEG biofeedback and rTMS
Treating Treatment Refractory Depression With TMS, Transcranial Magnetic Stimulation. TMS is for patients suffering from depression who have not achieved satisfactory improvement from prior antidepressant treatment. These slides show research and anecdotes taken from actual results of patients who've tried TMS.
Update by Dr. Lew Lim, Founder & CEO of VielightSharpBrains
During Expo Day selected Summit Sponsors and Partners showcased their most promising brain health & wellness initiatives and solutions.
Dr. Lew Lim, Founder & CEO of Vielight, will explore the latest on photobiomodulation and brain stimulation.
Slidedeck supporting presentation and discussion during the 2019 SharpBrains Virtual Summit: The Future of Brain Health (March 7-9th). Learn more at:
https://sharpbrains.com/summit-2019/
Prevalence of nerve conduction study to determine the prognostic value in Bel...AI Publications
Objective: To assess and compare side to side nerve conduction amplitude and degree of recovery facial nerve in bell’s palsy patients. METHODS: The present study was conducted on 23 Bell’s palsy patients (Aged 20-40 years) within 2week after onset of disease, in department of physiology with collaboration with department of ENT in JLN medical college and attached hospitals, Ajmer. Motor nerve conduction and latency recorded. Patient was made to lie down and surface electrodes were fixed over the skin which is on the nerve and supplying muscle. By stimulating the nerve at two different point and record motor evoke response. Result: Motor response is reduced in facial nerve; If motor response is <10% of normal (moderate-to-severe).recovery time is 6-12month.; If motor response is 10-30% of normal (mild-to-moderate) recovery time is 2-8month.; If motor response is >30% of normal complete recovery expected within 2month. Conclusion: Present study concluded that early recovery (within 2 months) recorded in patients with motor response is >30% of normal as compared to patients with motor response is <10% compared to healthy side. (Within 6-12 months). NCS is used to as an important tool to diagnose and prognoses the facial neuropathy in the Bell’s palsy patients. Significance: Present Study signifies the importance of nerve conduction studies in early initiation of treatment and recovery of facial neuropathy in Bell’s palsy patients.
My presentation delivered at the MS Symposium of the Jewish Hospital Berlin (https://www.juedisches-krankenhaus.de/home.html) held on 29 Nar 2023 at the Centrum Judaicum, Oranienburger Strasse, Berlin
BUPIVACAINE epidural effectiveness has a clearly scientific evidence for perioperative analgesia
Bupivacaine epidural still safe in a wide range dose to cause systemic toxicity
We always reduce the risk of LA toxicity by our usually practice procedures
Topography and functional significance of the dopaminesgic dysfunction in sch...wef
Presentation made by Dr. Anissa Abi-Dargham at the Schizophrenia Research Forum's live webinar of May 4, 2017 - Dopamine in Schizophrenia—Cortical and Subcortical Pathophysiology - review recording of session at http://www.schizophreniaforum.org/forums/dopamine-schizophrenia%E2%80%94cortical-and-subcortical-pathophysiology
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Photobiomodulation for Depression: Roadmap Towards Dose-Definition
1. Photobiomodulation
for Depression:
Roadmap Towards
Dose-Definition
Nov 14, 2020 – Virtual Session
celg – INOVACAO – Brazil
Paolo Cassano MD, PhD
Assistant Professor of Psychiatry
Harvard Medical School
Director of Photobiomodulation
Depression and Clinical Research Program
Division of Neuropsychiatry
Massachusetts General Hospital
@paolo_cassano
@paolocassanomd
@pcassano
in/paolo-cassano-md-phd
37. High Irradiance
Irradiance: 700 mW/cm2
Total Energy 2.4 kJ
Irradiance: 300 mW/cm2
Total Energy 2.4 kJ
Low Irradiance
Irradiance: 50 mW/cm2
Total Energy 1.4 kJ
SMALL SURFACE
Wavelength: 808 nm
Locations: F3 and F4
Total Area: 24 cm2 (2 x 12 cm2)
TRIADE STUDY (CW)
40. MGH Depression Program
North Eastern University
Qianqian Fang
Anh Phong Tran
Yaoshen Yuan
Nathan Kline Institute, NY
Dan Iosifescu
LiteCure LLC.
Luis De Taboada
Mass General Hospital
Depression Program
Sam Petrie
Garrett Thomas
Richard Norton
David Mischoulon
Cris Cusin
Maurizio Fava
Andy Nierenberg
Anxiety Program
Meredith Ward
Eric Bui
Tatiana Sitnikova
Mari Franceschini
Michael Hamblin
Husam Katnani
Mass Eye and Ear.
Benjamin BleierUniversity of Pisa
Vincenza Spera
Marco Maiello
